Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual Sites

Shayan Hobbi1 IBM Consulting, Bethesda, MD, USA;2 Accenture Federal Services, Arlington, VA, USA

Patrick Saunders-Hastings3 Accenture, Ottawa, Ontario, CanadaCorrespondence[email protected]

Cindy Ke Zhou4 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Jeffrey Beers1 IBM Consulting, Bethesda, MD, USA

Ananth Srikrishnan1 IBM Consulting, Bethesda, MD, USA

Aaron Hettinger5 MedStar Health Research Institute, Washington, DC, USA;6 School of Medicine, Georgetown University, Washington, DC, USA

Aarthi Shenoy5 MedStar Health Research Institute, Washington, DC, USA

Timothy Burrell1 IBM Consulting, Bethesda, MD, USA

Keran Moll1 IBM Consulting, Bethesda, MD, USA

Patricia C Lloyd4 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Steven A Anderson4 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Azadeh Shoaibi4 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Hui-Lee Wong4 Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Your download is now in progress and you may close this window